You are a key healthcare player, who develops and/or markets medicines, vaccines, medical devices or in-vitro diagnostics.

You are looking for a provider able to  optimise the value of your products to health authorities and other decision makers, in order to maximize their reimbursement level.

stève consultants is a consulting specialist in Market Access, RWE studies and HEOR studies. Our qualified consultants, our network and our human approach focusing on deliverables quality and timelines compliance makes our company a key player in France since 2006.

More than 12
years of experience
More than 20
More than 120
loyal customers

Stève Bénard – Executive Director

Josselin Boussel, Head of Market access
of stève consultants since 2010

Market access

For more than 10 years, stève consultants has been specialized in:

  • strategic consulting for pricing & reimbursement,
  • developing arguments and estimating target populations,
  • writing of reimbursement dossiers for French health authorities (transparency, CNEDiMTS and economic dossiers).

Our bonus: Working closely with you through evaluations by the French National Authority for Health (HAS) as well as through pricing negotiations with the French Economic Committee of Healthcare Products (CEPS).

Health-economic modeling

Our dedicated consultants conceive and develop:

  • health economic evaluations for health authorities (efficiency evaluation for the French Economic Committee of Evaluations in Public Health (CEESP), pricing negotiations with the CEPS…)

  • simulation tools to serve the medico-marketing strategy

Design /

  • cost-effectiveness model

  • cost-utility model

  • budget impact model


  • epidemiology and clinical inputs

  • healthcare consumption

  • unit costs


  • main analysis

  • uncertainty analysis

  • technical report

Our bonus: Strategic and technical guidance alongside the project.

Fanny Porte, HEOR Consultant

Charlotte Cancalon, Health-economist statistician
of stève consultants since 2009

Real-world evidence

stève consultants realises your observational studies from databases, notably claims ones (PMSI, EGB, SNIIRAM):

  • post-inscription studies required by health authorities,

  • ad-hoc pharmaco-epidemiological, epidemiological or health-economic studies to sustain your Market access strategy


schema 1 observational

use studies

schema 2 observational


schema 3 observational

real life

schema 4 observational

Our bonus: Support of a dedicated scientific steering committee / possible cross with clinical registries or physicians’ panels.